Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Study evaluates number of needed to refer, biopsy for diagnosing a melanoma

Key clinical point: Despite variable rates of skin cancer between demographics, the mean biopsy rate was 23.4%.Major finding: The number needed to treat for melanoma was 31.5 and the number needed to biopsy was 7.5. Meanwhile, the number needed to refer for nonmelanoma skin cancer was 4, and the number needed to biopsy was 1.5.

Study details: A retrospective review of 707 patients referred to a single tertiary medical center dermatology practice.

Disclosures: The study was supported by the Alpha Omega Alpha Carolyn Kuckein Research Fellowship. The researchers reported having no financial disclosures.

Citation:

Klebanov N et al. AAD 20. Abstract 15881.